Venture Pre-Screen · U.S. Market PotentialUpload your pitch deck. Numen Ventures scores it against 13 venture criteria weighted for your funding stage, out of 120 — plus a separate U.S. Market Potential Assessment across 15 sub-criteria in 4 areas, out of 120, and a risk rating that is not a summary of either.
Built primarily for startup companies entering the US market.
No account needed · Your deck is not shared · Report in 1–2 minutes
Seed or Series A. Required, with no default: the stage sets every weight below it, and traction alone swings from 14 points to 18 across them.
PDF or PPTX. Speaker notes are read too, since that is often where the numbers actually live.
Each item is scored 0–10 on the evidence present in the deck — not on how ambitious the claim is. A confident assertion with no supporting figure scores low. The 120-point venture total and the 120-point U.S. Market Potential score are calculated separately.
Evidence across the rubric is specific, quantified, and consistent.
Real substance, with named areas still carried on assertion.
The shape of the case is present; the evidence for it is not yet.
Core claims are not yet evidenced. Validate before scaling.
The weighted total is calculated in code, not written by the model. Risk is calculated separately and is not a summary of the score — a deck can score well and still carry high risk if its traction, go-to-market, or US evidence is thin.
Questions, or want your report looked at by a human? Email info@numenventures.co.
Scored separately, and deliberately so. A company can be a strong investment and still have little to show for the US; folding the two into one number hides exactly the signal this is here to surface. These weights do not move with the stage — being early does not change a company’s potential in a market.
The case for this company in the U.S. is specific, evidenced and coherent.
Real potential, with named gaps that should be closed before entry.
The shape of a U.S. opportunity is present; the evidence for it is not yet.
The U.S. case rests on assumptions that have not been tested against U.S. buyers.
The whole product. A stage-weighted venture score, a separate U.S. Market Potential Assessment, and a risk rating that is not a summary of either.